These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 36800625
1. Diagnosis, treatment, and genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A review. Wang Y, Xiao L, Yin L, Zhou L, Deng Y, Deng H. Medicine (Baltimore); 2023 Feb 17; 102(7):e32904. PubMed ID: 36800625 [Abstract] [Full Text] [Related]
2. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations. Shumilov E, Mazzeo P, Ghandili S, Künstner A, Weidemann S, Banz Y, Ströbel P, Pollak M, Kolloch L, Beltraminelli H, Kerkhoff A, Mikesch JH, Schliemann C, Haase D, Wulf G, Legros M, Lenz G, Feldmeyer L, Pabst T, Witte H, Gebauer N, Bacher U. Ann Hematol; 2024 May 17; 103(5):1587-1599. PubMed ID: 38194088 [Abstract] [Full Text] [Related]
14. Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark. Taylor J, Haddadin M, Upadhyay VA, Grussie E, Mehta-Shah N, Brunner AM, Louissaint A, Lovitch SB, Dogan A, Fathi AT, Stone RM, Tallman MS, Rampal RK, Neuberg DS, Stevenson KE, Horwitz SM, Lane AA. Blood; 2019 Aug 22; 134(8):678-687. PubMed ID: 31243042 [Abstract] [Full Text] [Related]
15. Blastic plasmacytoid dendritic cell neoplasm: emerging developments and special considerations for 2023. Pemmaraju N, Kantarjian H. Clin Adv Hematol Oncol; 2023 May 22; 21(5):257-264. PubMed ID: 37145496 [Abstract] [Full Text] [Related]